Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Recursion Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $435.0K in total
Insiders trading
2
Net value
−$435.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Recursion Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Recursion Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Taylor Ben RChief Financial Officer1,071,462Sep 16, 202612
Khan NajatCEO and President2,072,890Sep 10, 202610
Borgeson BlakeDirector6,158,287Sep 2, 202611
Hallett DavidChief Scientific Officer1,043,837Aug 18, 20264
Dar ZavainDirector240,764Jul 2, 20265
Li Dean YDirector1,473,329Jul 2, 20265
Hershberg RobertDirector162,156Jun 22, 20261
Sun Elaine DDirector135,981Jun 22, 20261
Michor FranziskaDirector215,477Jun 22, 20261
Bumpus NamandjeDirector127,632Jun 22, 20262
Gibson ChristopherDirector883,735Jun 5, 202618
Mauro David JChief Medical Officer225,429Nov 19, 20240
Secora MichaelChief Financial Officer1,487,694Nov 19, 20240
Larson Tina MarriottPresident and COO506,852Nov 19, 20240
Burrell Terry-AnnDirector71,254Jul 3, 20240
Chavez R. MartinDirector60,078Apr 3, 20240
Virani ShafiqueChief Business Officer136,748Jan 18, 20240
Bogue ZacharyDirector, 10% Owner9,378Jul 6, 20230
Mamoura Diversified Global Holding PJSC10% Owner12,985,927IndirectMar 3, 20230
Mubadala Investment Co PJSC10% Owner12,985,927IndirectMar 3, 20230
Doyle RamonaChief Medical Officer121,110May 18, 20220
Lux Ventures IV, L.P.Other: Former 10% Owner13,021,519Dec 9, 20210
Lux Venture Partners IV, LLCOther: Former 10% Owner13,021,519Dec 9, 20210
Hebert PeterOther: Former 10% Owner13,021,519Dec 9, 20210
Lux Co-Invest Partners, LLCOther: Former 10% Owner13,021,519Dec 9, 20210
Lux Co-Invest Opportunities, L.P.Other: Former 10% Owner13,021,519Dec 9, 20210
Wolfe JoshOther: Former 10% Owner13,021,519Dec 9, 20210
Mic Capital Partners (Public) (US) Im, LLCOther: See remarks–Nov 3, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 14, 2023 (view filing)Dec 122 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$7.40−$84.7K−0.2%7.38M after10b5-1
Dec 14, 2023 (view filing)Dec 12-132 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$7.49−$374.5K−5.0%956.0K after2 lots10b5-1
Dec 18, 2023 (view filing)Dec 144 daysDar ZavainDirectorSSaleClass A Common Stock−20.1K$9.00−$181.3K−27.2%53.8K after10b5-1
Dec 19, 2023 (view filing)Dec 154 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−18.0K$9.60−$172.8K−11.6%136.7K after10b5-1
Dec 28, 2023 (view filing)Dec 262 daysBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$10.63−$213.2K−0.3%7.36M after10b5-1
Jan 2, 2024 (view filing)Dec 28, 20235 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−8.00K$10.58−$84.6K−1.9%414.5K after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−30.9K$9.49−$292.8K−3.8%791.7K after
Jan 5, 2024 (view filing)Jan 32 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$9.51−$237.7K−100.0%0 after3 lots
Jan 11, 2024 (view filing)Jan 92 daysBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$13.62−$273.2K−0.3%7.34M after2 lots10b5-1
Jan 11, 2024 (view filing)Jan 92 daysLi Dean YDirectorSSaleClass A Common Stock−29.0K$13.66−$396.2K−6.4%421.0K after2 lots10b5-1
Jan 18, 2024 (view filing)Jan 16-172 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$10.35−$517.5K−4.8%981.0K after2 lots10b5-1
Jan 18, 2024 (view filing)Jan 162 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−18.0K$10.93−$196.7K−11.6%136.7K after10b5-1
Jan 25, 2024 (view filing)Jan 232 daysBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$10.58−$212.2K−0.3%7.32M after10b5-1
Jan 29, 2024 (view filing)Jan 254 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−8.00K$10.35−$82.8K−1.9%414.5K after10b5-1
Feb 8, 2024 (view filing)Feb 62 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$9.30−$106.5K−0.2%7.31M after10b5-1
Feb 9, 2024 (view filing)Feb 72 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−48.3K$9.22−$445.1K−5.9%774.7K after
Feb 15, 2024 (view filing)Feb 13-142 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$10.16−$507.8K−4.0%1.19M after3 lots10b5-1
Feb 21, 2024 (view filing)Feb 201 dayBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$12.32−$247.1K−0.3%7.29M after2 lots10b5-1
Feb 23, 2024 (view filing)Feb 221 dayLarson Tina MarriottPresident and COOSSaleClass A Common Stock−8.00K$14.90−$119.2K−1.2%640.0K after10b5-1
Mar 7, 2024 (view filing)Mar 52 daysBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$12.06−$241.9K−0.3%7.27M after10b5-1
Mar 8, 2024 (view filing)Mar 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−36.3K$11.86−$430.7K−3.2%1.11M after
Mar 8, 2024 (view filing)Mar 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$11.55−$288.8K−100.0%0 after3 lots
Mar 14, 2024 (view filing)Mar 12-132 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$10.75−$537.3K−4.0%1.20M after2 lots10b5-1
Mar 21, 2024 (view filing)Mar 192 daysBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$10.79−$216.4K−0.3%7.25M after10b5-1
Mar 25, 2024 (view filing)Mar 214 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−8.00K$10.75−$86.0K−1.2%640.0K after2 lots10b5-1
Apr 1, 2024 (view filing)Mar 284 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−40.0K$10.10−$404.0K−3.7%1.04M after10b5-1
Apr 1, 2024 (view filing)Mar 284 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$10.10−$252.5K−100.0%0 after10b5-1
Apr 3, 2024 (view filing)Apr 21 dayBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$8.82−$101.0K−0.2%7.24M after10b5-1
Apr 5, 2024 (view filing)Apr 3-42 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−80.0K$8.93−$714.4K−7.9%938.5K after2 lots10b5-1
Apr 5, 2024 (view filing)Apr 3-42 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−50.0K$8.93−$446.5K−100.0%0 after2 lots10b5-1
Apr 18, 2024 (view filing)Apr 16-172 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−48.1K$7.63−$367.0K−3.8%1.23M after2 lots10b5-1
Apr 18, 2024 (view filing)Apr 162 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$7.66−$87.7K−0.2%7.23M after10b5-1
Apr 29, 2024 (view filing)Apr 254 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$7.67−$23.0K−0.5%543.2K after10b5-1
May 2, 2024 (view filing)Apr 302 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$7.95−$91.0K−0.2%7.22M after10b5-1
May 3, 2024 (view filing)May 1-22 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−100.0K$8.10−$810.0K−10.7%834.8K after3 lots10b5-1
May 16, 2024 (view filing)May 142 daysBorgeson BlakeDirectorSSaleClass A Common Stock−20.1K$10.12−$202.9K−0.3%7.20M after10b5-1
May 30, 2024 (view filing)May 282 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$9.17−$105.0K−0.2%7.19M after10b5-1
Jun 3, 2024 (view filing)May 304 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$8.78−$26.3K−0.6%535.5K after10b5-1
Jun 7, 2024 (view filing)Jun 5-62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−100.0K$8.71−$871.0K−12.4%708.7K afterFrom original2 lots10b5-1
Jun 13, 2024 (view filing)Jun 112 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$8.45−$96.7K−0.2%7.19M after10b5-1
Jun 17, 2024 (view filing)Jun 13-144 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−30.0K$9.30−$278.9K−2.3%1.27M after2 lots10b5-1
Jun 27, 2024 (view filing)Jun 252 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$9.51−$108.9K−0.2%7.18M after10b5-1
Jun 28, 2024 (view filing)Jun 271 dayLarson Tina MarriottPresident and COOSSaleClass A Common Stock−6.00K$7.22−$43.3K−1.1%535.5K after10b5-1
Jul 11, 2024 (view filing)Jul 92 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$7.32−$83.8K−0.2%7.17M after10b5-1
Jul 11, 2024 (view filing)Jul 9-102 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−30.0K$7.28−$218.4K−2.2%1.32M after2 lots10b5-1
Jul 12, 2024 (view filing)Jul 10-112 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−100.0K$7.48−$747.5K−11.6%758.7K after2 lots10b5-1
Jul 25, 2024 (view filing)Jul 232 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$8.48−$97.1K−0.2%7.16M after10b5-1
Jul 29, 2024 (view filing)Jul 254 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−6.00K$8.13−$48.8K−1.1%535.5K after10b5-1
Aug 8, 2024 (view filing)Aug 62 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$6.82−$78.1K−0.2%7.14M after10b5-1
Aug 9, 2024 (view filing)Aug 7-82 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−50.0K$6.86−$343.0K−6.2%758.7K after2 lots10b5-1